Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rosenstein

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Journal of Pediatric Psychology|May 8, 2009
Description of a standardized nutrition classification plan and its relation to nutritional outcomes in children with cystic fibrosisAmanda Leonard, Erin Davis, Beryl J Rosenstein, et al.
The Journal of Pediatrics|September 1, 1979
Noninvasive evaluation of ventricular function in cystic fibrosisB E Chipps, P O Alderson, J M Roland, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 3, 1998
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effectsM K Stafford, H Ward, A Flanagan, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 1996
Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosisB L Laube, R M Auci, D E Shields, et al.
The New England Journal of Medicine|March 23, 2000
Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosisH C Lai, S C FitzSimmons, D B Allen, et al.
Joint Commission Journal on Quality and Safety|February 28, 2004
Senior executive adopt-a-work unit: a model for safety improvementPeter J Pronovost, Brad Weast, Kate Bishop, et al.
American Journal of Human Genetics|August 1, 1992
Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileusA Hamosh, T M King, B J Rosenstein, et al.
Journal of Thrombosis and Haemostasis : JTH|July 8, 2021
Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trialUsha S Perepu, Isaac Chambers, Abdul Wahab, et al.
American Journal of Human Genetics|May 1, 1997
Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%M Macek, A Mackova, A Hamosh, et al.
Quality & Safety in Health Care|December 4, 2003
Evaluation of the culture of safety: survey of clinicians and managers in an academic medical centerP J Pronovost, B Weast, C G Holzmueller, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Journal of Pediatric Psychology|May 8, 2009
Description of a standardized nutrition classification plan and its relation to nutritional outcomes in children with cystic fibrosisAmanda Leonard, Erin Davis, Beryl J Rosenstein, et al.
The Journal of Pediatrics|September 1, 1979
Noninvasive evaluation of ventricular function in cystic fibrosisB E Chipps, P O Alderson, J M Roland, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 3, 1998
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effectsM K Stafford, H Ward, A Flanagan, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 1996
Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosisB L Laube, R M Auci, D E Shields, et al.
The New England Journal of Medicine|March 23, 2000
Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosisH C Lai, S C FitzSimmons, D B Allen, et al.
Joint Commission Journal on Quality and Safety|February 28, 2004
Senior executive adopt-a-work unit: a model for safety improvementPeter J Pronovost, Brad Weast, Kate Bishop, et al.
American Journal of Human Genetics|August 1, 1992
Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileusA Hamosh, T M King, B J Rosenstein, et al.
Journal of Thrombosis and Haemostasis : JTH|July 8, 2021
Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trialUsha S Perepu, Isaac Chambers, Abdul Wahab, et al.
American Journal of Human Genetics|May 1, 1997
Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%M Macek, A Mackova, A Hamosh, et al.
Quality & Safety in Health Care|December 4, 2003
Evaluation of the culture of safety: survey of clinicians and managers in an academic medical centerP J Pronovost, B Weast, C G Holzmueller, et al.
Pageof 13